Child psychosis study aims to match kids to the right drug
NCT ID NCT04370730
First seen Jan 25, 2026 · Last updated Jun 19, 2026 · Updated 21 times
Summary
This study is following 200 children and teens (ages 7-20) who have experienced psychosis to see if they fall into distinct subgroups. Researchers will use interviews, brain scans, and genetic tests to classify participants. The goal is to see if these subgroups predict how well a child responds to specific antipsychotic medications, potentially leading to more personalized treatment in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHRU de Lille
NOT_YET_RECRUITINGLille, 59037, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU de Nice
NOT_YET_RECRUITINGNice, 62000, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Rouen
NOT_YET_RECRUITINGRouen, 76031, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU de Rouvray
NOT_YET_RECRUITINGRouen, 76031, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Fondation Vallée, Gentilly
NOT_YET_RECRUITINGGentilly, 94257, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Pitié Salpétrière
RECRUITINGParis, 75013, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors identify which antipsychotic drug works best for a child based on their specific psychosis subtype, leading to more personalized treatment.
What could go wrong
This is an observational study, not a treatment trial. It may not lead to immediate changes in care, and the findings might not apply to all children with psychosis.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.